|
 |
The HemoCue Glucose Systems are based on a glucose dehydrogenase method and consists of a small, dedicated analyzer and a unique disposable microcuvette. The systems combine the precision and accuracy of a central laboratory with the speed and convenience of obtaining results at the point-of-care. Following the three simple steps, the HemoCue Glucose Systems will produce lab-accurate results for diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels. |
 |
|
|
 |
|
 |
- Lab-accurate results - Glucose 201 Analyzer: 0-444 mg/dL (0-24.6 mmol/L) - Only 5 µL of capillary, venous, or arterial blood is needed - No inherent limitations related to hematocrit or known drug interferences - No recalibration needed between cuvette lots |
 |
|
|
 |
|
 |
The microcuvette is made of plastic and contains a cavity that holds about 5 µL of sample. The cuvette cavity contains reagents deposited on its inner walls and the blood sample is drawn into the cavity by capillary action and spontaneously mixed with the reagents. The cuvette is then placed into the analyzer in which the transmittance is measured and the absorbance and glucose level is calculated. Glucose 201 Microcuvettes cannot be used in B-Glucose Systems and vice versa. Individually packaged microcuvettes for the HemoCue Glucose 201 Analyzer are available. The individually packaged cuvettes can be stored at room temperature for up to 3 days. |
 |
|
|
 |